NSF International, a global independent public health organization with 66 years of experience, including 25 years of pharmaceutical expertise through its NSF Health Sciences Division, is launching ...

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows WALTHAM, Mass., June 02, ...

The analysis of next-generation sequencing (NGS) data is complex, owing to the breadth of sequences tested and the range of internal biases and errors. In a clinical context, this can lead to false ...

WALTHAM, Mass., November 10, 2025--(BUSINESS WIRE)--Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Horizon Diagnostics (HDx) has announced that it has launched its first Quantitative Multiplex DNA Reference Standard. This standard is the first of its kind and is intended for researchers assessing ...

Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European ...

Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard.

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows “Accurate diagnosis, including ...